Venlafaxine Hydrochloride for the Treatment of Hot Flashes

Annals of Pharmacotherapy

Volumn 37, Issue 11, 2003, Pages 1703-1707

  Schober, Christina E ^a   Ansani, Nicole T ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Effexor; Hot flashes; Vasomotor symptoms; Venlafaxine

Indexed keywords

ALPHA TOCOPHEROL; BELLADONNA ALKALOID; CLONIDINE; FLUOXETINE; GABAPENTIN; HERBACEOUS AGENT; MEGESTROL ACETATE; METHYLDOPA; PAROXETINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANOREXIA; BODY WEIGHT DISORDER; CANCER; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; ESTROGEN THERAPY; FATIGUE; HOT FLUSH; HUMAN; HYPERHIDROSIS; LOW DRUG DOSE; NAUSEA; NERVOUSNESS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; WEIGHT GAIN; XEROSTOMIA;

CLINICAL TRIALS; CYCLOHEXANOLS; FEMALE; HOT FLASHES; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 0142244562     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C483     Document Type: Review

References (16)

1. Braunwald E, Fauci AS, Isselbacher KJ, Kasper DL, Hauser SL, Longo DL, et al., eds. Harrison's online [Online Medical Bookstore]. 15th ed. New York: McGraw-Hill Education, 2002.
2. Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes: aetiology and management. Drugs Aging 2001;18:597-606.
3. Smith MR. Complementary and alternative therapies for advanced prostate cancer. Hematol Oncol Clin North Am 2001;15:559-71.
4. Quella SK, Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, et al. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol 1999;162:98-102.
5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002;288:321-33.
6. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998;16:2377-81.
7. Thiedke CC. Nonhormonal pharmacologic and complementary treatment of menopause. Clin Fam Pract 2002;4:115-71.
8. Clayden JR, Bell JW, Pollard P. Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J 1974;1:409-12.
9. Pritchard KI. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives. Ann Oncol 2001;12:301-10.
10. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63.
11. Barton D, LaVasseur B, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum 2002;29:33-40.
12. Grady-Weliky TA, Hartmann DM. Flushing in a menopausal woman taking venlafaxine (letter). Am J Psychiatry 2001;158:1330.
13. Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17-22.
14. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Scella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-83.
15. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23:337-45.
16. Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer. Psychooncology 1998;7:129-32.